Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desvenlafaxine in Postpartum Depression
NCT01527786Phase 3Completed
- Sponsor
- BC Women's Hospital & Health Centre
- Start
- Nov 2010
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of desvenlafaxine in postpartum depression (PPD), sponsored by BC Women's Hospital & Health Centre. Primary endpoint: Sheehan Disability Scale at 12 weeks. Started Nov 2010; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT01527786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01527786.